TY  - JOUR
AU  - Montes, Paola
AU  - Guerra-Librero, Ana
AU  - Garcia, Paloma
AU  - Cornejo-Calvo, María Elena
AU  - Lopez, Maria del Señor
AU  - Haro, Tomas de
AU  - Martinez-Ruiz, Laura
AU  - Escames, Germaine
AU  - Acuña-Castroviejo, Dario
PY  - 2022
DO  - 10.3390/antiox11010139
SN  - 2076-3921
UR  - http://hdl.handle.net/10668/20770
T2  - Antioxidants (Basel, Switzerland)
AB  - This study focused on the impact of the treatment with the hypomethylating agent 5-azacitidine on the redox status and inflammation in 24 MDS patients. Clinical and genetic features of MDS patients were recorded, and peripheral blood samples were used...
LA  - en
KW  - 5-azacitidine
KW  - cytokines
KW  - inflammation
KW  - myelodysplastic syndrome (MDS)
KW  - oxidative stress
KW  - somatic alterations
KW  - Advanced Oxidation Protein Products
KW  - Glutathione Disulfide
KW  - Interleukin-2
KW  - Lipid Peroxidation
KW  - Risk Factors
TI  - Effect of 5-Azacitidine Treatment on Redox Status and Inflammatory Condition in MDS Patients.
TY  - research article
VL  - 11
ER  -